[1]肖锦 孙敏 张冬颖.心力衰竭患者骨骼肌改变及其临床意义[J].心血管病学进展,2023,(9):828.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.014]
 XIAO Jin,SUN Min,ZHANG Dongying.Clinical Significance of Skeletal Muscle Changes in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2023,(9):828.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.014]
点击复制

心力衰竭患者骨骼肌改变及其临床意义()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年9期
页码:
828
栏目:
综述
出版日期:
2023-09-25

文章信息/Info

Title:
Clinical Significance of Skeletal Muscle Changes in Patients with Heart Failure
作者:
肖锦 孙敏 张冬颖
(重庆医科大学附属第一医院心血管内科,重庆 400016)
Author(s):
XIAO JinSUN MinZHANG Dongying
(Department of Cardiovascular Medicine,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)
关键词:
心力衰竭骨骼肌改变肌肉
Keywords:
Heart failure Skeletal muscle changes Muscle
DOI:
10.16806/j.cnki.issn.1004-3934.2023.09.014
摘要:
心力衰竭患者可能合并骨骼肌改变,客观表现为肌肉质量减少、肌力下降、身体机能下降。同时,骨骼肌改变与心力衰竭及其预后密切相关,严重影响心力衰竭患者的生活质量,甚至增加心力衰竭患者再住院和死亡风险。现对心力衰竭患者的骨骼肌改变及其临床意义进行综述。
Abstract:
Patients with heart failure may have a combination of skeletal muscle changes,which objectively manifest as reduced muscle mass,decreased muscle strength,and decreased physical function. Meanwhile,the skeletal muscle changes are closely associated with heart failure and its prognosis,severely affecting the quality of life of patients with heart failure,and even increasing the risk of rehospitalization and death in patients with heart failure. This paper reviews skeletal muscle changes and its clinical significance in patients with heart failure

参考文献/References:

[1] Hao G,Wang X,Chen Z,et al. Prevalence of heart failure and left ventricular dysfunction in China:the China Hypertension Survey,2012-2015[J]. Eur J Heart Fail,2019,21(11):1329-1337.

[2] Fülster S,Tacke M,Sandek A,et al. Muscle wasting in patients with chronic heart failure:results from the studies investigating co-morbidities aggravating heart failure(SICA-HF)[J]. Eur Heart J,2013,34(7):512-519.

[3] Cruz-Jentoft AJ,Bahat G,Bauer J,et al. Sarcopenia:revised European consensus on definition and diagnosis[J]. Age Ageing,2019,48(1):16-31.

[4] Mancini DM,Walter G,Reichek N,et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure[J]. Circulation,1992,85(4):1364-1373.

[5] Haykowsky MJ,Brubaker PH,Morgan TM,et al. Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction:role of lean body mass[J]. J Gerontol A Biol Sci Med Sci,2013,68(8):968-975.

[6] Emami A,Saitoh M,Valentova M,et al. Comparison of sarcopenia and cachexia in men with chronic heart failure:results from the Studies Investigating Co-morbidities Aggravating Heart Failure(SICA-HF)[J]. Eur J Heart Fail,2018,20(11):1580-1587.

[7] Rahman A,Jafry S,Jeejeebhoy K,et al. Malnutrition and cachexia in heart failure[J]. JPEN J Parenter Enteral Nutr,2016,40(4):475-486.

[8] Porto JM,Nakaishi APM,Cangussu-Oliveira LM,et al. Relationship between grip strength and global muscle strength in community-dwelling older people[J]. Arch Gerontol Geriatr,2019,82:273-278.

[9] Loncar G,Bozic B,von Haehling S,et al. Association of adiponectin with peripheral muscle status in elderly patients with heart failure[J]. Eur J Intern Med,2013,24(8):818-823.

[10] Konishi M,Kagiyama N,Kamiya K,et al. Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction[J]. Eur J Prev Cardiol,2021,28(9):1022-1029.

[11] Weng SC,Lin CS,Tarng DC,et al. Physical frailty and long-term mortality in older people with chronic heart failure with preserved and reduced ejection fraction:a retrospective longitudinal study[J]. BMC Geriatr,2021,21(1):92.

[12] Parahiba SM,Spillere SR,Zuchinali P,et al. Handgrip strength in patients with acute decompensated heart failure:accuracy as a predictor of malnutrition and prognostic value[J]. Nutrition,2021,91-92:111352.

[13] Pavasini R,Serenelli M,Celis-Morales CA,et al. Grip strength predicts cardiac adverse events in patients with cardiac disorders:an individual patient pooled meta-analysis[J]. Heart,2019,105(11):834-841.

[14] World Health Organisation. Towards a common language for functioning,disability and health:ICF[M]. Geneva:World Health Organisation,2002.

[15] Cruz-Jentoft AJ,Baeyens JP,Bauer JM,et al. Sarcopenia:European consensus on definition and diagnosis:report of the European Working Group on Sarcopenia in Older People[J]. Age Ageing,2010,39(4):412-423.

[16] Mentz RJ,Whellan DJ,Reeves GR,et al. Rehabilitation intervention in older patients with acute heart?failure with?preserved versus reduced ejection?fraction[J]. JACC Heart Fail,2021,9(10):747-757.

[17] Iwatsu K,Ikeda T,Matsumura K,et al. Gap in the prognostic impact of short physical performance battery among phenotypes of heart failure[J]. Int J Cardiol,2022,361:85-90.

[18] Enright PL. The six-minute walk test[J]. Respir Care,2003,48(8):783-785.

[19] Faggiano P,D’Aloia A,Gualeni A,et al. The 6 minute walking test in chronic heart failure:indications,interpretation and limitations from a review of the literature[J]. Eur J Heart Fail,2004,6(6):687-691.

[20] Del Buono MG,Arena R,Borlaug BA,et al. Exercise intolerance in patients with heart failure:JACC state-of-the-art review[J]. J Am Coll Cardiol,2019,73(17):2209-2225.

[21] Peeters P,Mets T. The 6-minute walk as an appropriate exercise test in elderly patients with chronic heart failure[J]. J Gerontol A Biol Sci Med Sci,1996,51(4):M147-M151.

[22] Rostagno C,Olivo G,Comeglio M,et al. Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure:comparison with other methods of functional evaluation[J]. Eur J Heart Fail,2003,5(3):247-252.

[23] Studenski S,Perera S,Patel K,et al. Gait speed and survival in older adults[J]. JAMA,2011,305(1):50-58.

[24] Lo AX,Donnelly JP,McGwin G Jr,et al. Impact of gait speed and instrumental activities of daily living on all-cause mortality in adults≥65?years with heart failure[J]. Am J Cardiol,2015,115(6):797-801.

[25] Chaudhry SI,McAvay G,Chen S,et al. Risk factors for hospital admission among older persons with newly diagnosed heart failure:findings from the Cardiovascular Health Study[J]. J Am Coll Cardiol,2013,61(6):635-642.

[26] Ozawa T,Yamashita M,Seino S,et al. Standardized gait speed ratio in elderly patients with heart failure[J]. ESC Heart Fail,2021,8(5):3557-3565.

[27] Pulignano G,Del Sindaco D,di Lenarda A,et al. Incremental value of gait speed in predicting prognosis of older adults with heart failure:insights from the IMAGE-HF study[J]. JACC Heart Fail,2016,4(4):289-298.

[28] Drexler H,Riede U,Münzel T,et al. Alterations of skeletal muscle in chronic heart failure[J]. Circulation,1992,85(5):1751-1759.

[29] Seiler M,Bowen TS,Rolim N,et al. Skeletal muscle alterations are exacerbated in heart failure with reduced compared with preserved ejection fraction:mediated by circulating cytokines?[J]. Circ Heart Fail,2016,9(9):e003027.

[30] Mettauer B,Zoll J,Sanchez H,et al. Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects[J]. J Am Coll Cardiol,2001,38(4):947-954.

[31] Hambrecht R,Adams V,Gielen S,et al. Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle[J]. J Am Coll Cardiol,1999,33(1):174-179.

[32] Kitzman DW,Nicklas B,Kraus WE,et al. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction[J]. Am J Physiol Heart Circ Physiol,2014,306(9):H1364-H1370.

[33] Newman AB,Simonsick EM,Naydeck BL,et al. Association of long-distance corridor walk performance with mortality,cardiovascular disease,mobility limitation,and disability[J]. JAMA,2006,295(17):2018-2026.

[34] Kadariya D,Canada JM,Del Buono MG,et al. Peak oxygen uptake recovery delay after maximal exercise in patients with heart failure[J]. J Cardiopulm Rehabil Prev,2020,40(6):434-437.

[35] Vale-Lira A,Turri-Silva N,Verboven K,et al. Muscle-skeletal abnormalities and muscle oxygenation during isokinetic strength exercise in heart failure with preserved ejection fraction phenotype:a cross-sectional study[J]. Int J Environ Res Public Health,2022,19(2):709.

相似文献/References:

[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
 DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(9):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
 LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(9):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
 ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(9):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
 LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(9):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
 KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(9):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
 SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(9):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
 XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(9):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
 GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(9):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[9]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
 HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(9):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[10]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
 WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(9):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]

更新日期/Last Update: 2023-10-17